Literature DB >> 6069927

Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.

W D da Silva, J W Eisele, I H Lepow.   

Abstract

Purified preparations of human C'1 esterase, C'4, C'2, C'3, and C'5 were labeled with (125)I. Reaction mixtures were prepared containing a single labeled component and other unlabled components. After incubation at 37 degrees C for 10 min at pH 7.4 in the presence of 5 x 10(-4)M Mg(2+), they were adjusted to pH 3.5 and subjected to sucrose density gradient ultracentrifugation and gel filtration at pH 3.5. In all cases, an activity capable of contracting guinea pig ileum with tachyphylaxis was obtained in low molecular weight fractions. However, these fractions were labeled only when (125)I-C'3 was employed, indicating that biological activity was associated with a cleavage product of C'3. This fragment has been designated F(a)C'3 in a nomenclature consistent with that of immunoglobulin degradation products. The much larger, residual portion of the C'3 molecule has been designated F(b)C'3. The biochemical characteristics of generation of F(a)C'3 were consistent with a mechanism involving action of C'1 esterase on C'4 and C'2, activation of C'2, and cleavage of C'3. F(a)C'3 had a molecular weight by gel filtration techniques of 6800 or less. It was thermostable and susceptible to inactivation by endo- and exopeptidases. The isolated fragment possessed all of the biological properties of unfractionated mixtures of C'1 esterase, C'4, C'2, and C'3. In addition to contraction of guinea pig ileum, these included failure to contract rat uterus, enhancement of vascular permeability in guinea pig skin, degranulation of mast cells in guinea pig mesentery, and release of histamine from rat peritoneal mast cells. F(a)C'3 did not cross-desensitize guinea pig ileum to rat agar anaphylatoxin and vice versa. The existence of different protein fragments with anaphylatoxin properties has been discussed. Distinctive characteristics of F(a)C'3 from classical anaphylatoxin generated by treatment of fresh rat serum with agar have been indicated.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6069927      PMCID: PMC2138425          DOI: 10.1084/jem.126.6.1027

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.

Authors:  A L HAINES; I H LEPOW
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  High specific activity iodination of gamma-globulin with iodine-131 monochloride.

Authors:  R W HELMKAMP; R L GOODLAND; W F BALE; I L SPAR; L E MUTSCHLER
Journal:  Cancer Res       Date:  1960-11       Impact factor: 12.701

3.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

4.  Release of histamine from mast cells by antigen-antibody reactions in vitro.

Authors:  G T ARCHER
Journal:  Aust J Exp Biol Med Sci       Date:  1960-04

5.  Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.

Authors:  A P Dalmasso; H J Müller-Eberhard
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

6.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

7.  Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.

Authors:  H J Müller-Eberhard; M J Polley; M A Calcott
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

8.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

9.  THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.

Authors:  G B NAFF; J PENSKY; I H LEPOW
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

10.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

View more
  46 in total

Review 1.  C4a: An Anaphylatoxin in Name Only.

Authors:  Scott R Barnum
Journal:  J Innate Immun       Date:  2015-02-06       Impact factor: 7.349

Review 2.  [Recent perspectives on the mechanisms of rejection in kidney transplantation (author's transl)].

Authors:  V Lenhard; K Resch; K Dreikorn; E Ritz
Journal:  Klin Wochenschr       Date:  1978-01-15

3.  Uptake of 125I-labelled C3a by cultured human endothelial cells.

Authors:  J B Denney; A R Johnson
Journal:  Immunology       Date:  1979-02       Impact factor: 7.397

4.  Interactions of the complement system with endotoxic lipopolysaccharide: the generation of an anaphylatoxin.

Authors:  L M Lichtenstein; H Gewurz; N F Adkinson; H S Shin; S E Mergenhagen
Journal:  Immunology       Date:  1969-03       Impact factor: 7.397

5.  Further characterization of a factor from endotoxin-treated serum which releases histamine and heparin from mast cells.

Authors:  W A Hook; R Snyderman; S E Mergenhagen
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

6.  A new biologically active peptide system in serum related to classical anaphylatoxin.

Authors:  J H Wissler
Journal:  Experientia       Date:  1971-12-15

7.  Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.

Authors:  J Greenblatt; R J Boackle; J H Schwab
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

8.  Limiting factors of the anaphylatoxin forming system in plasma from different species.

Authors:  R Brandt; D Schwoerer; W Vogt
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

9.  The antigen-induced degranulation of basophil leucocytes from atopic subjects, studied by phase-contrast microscopy.

Authors:  R Hastie
Journal:  Clin Exp Immunol       Date:  1971-01       Impact factor: 4.330

10.  Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization.

Authors:  V H Donaldson; O D Ratnoff; W Dias Da Silva; F S Rosen
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.